Departments of Biochemistry and Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53506, USA.
Science. 2024 Nov 8;386(6722):667-672. doi: 10.1126/science.adp7201. Epub 2024 Nov 7.
One-fifth of human proteins are N-glycosylated in the endoplasmic reticulum (ER) by two oligosaccharyltransferases, OST-A and OST-B. Contrary to the prevailing view of N-glycosylation as a housekeeping function, we identified an ER pathway that modulates the activity of OST-A. Genetic analyses linked OST-A to HSP90B1, an ER chaperone for membrane receptors, and CCDC134, an ER luminal protein. During its translocation into the ER, an N-terminal peptide in HSP90B1 templates the assembly of a translocon complex containing CCDC134 and OST-A that protects HSP90B1 during folding, preventing its hyperglycosylation and degradation. Disruption of this pathway impairs WNT and IGF1R signaling and causes the bone developmental disorder osteogenesis imperfecta. Thus, N-glycosylation can be regulated by specificity factors in the ER to control cell surface receptor signaling and tissue development.
五分之一的人类蛋白质在 ER 中通过两种寡糖基转移酶 OST-A 和 OST-B 进行 N-糖基化。与 N-糖基化作为一种管家功能的流行观点相反,我们鉴定出一种 ER 途径,该途径调节 OST-A 的活性。遗传分析将 OST-A 与 HSP90B1 (一种膜受体的 ER 伴侣)和 CCDC134 (一种 ER 腔蛋白)联系起来。在其转运到 ER 期间,HSP90B1 的 N 端肽模板组装包含 CCDC134 和 OST-A 的易位复合物,该复合物在折叠过程中保护 HSP90B1,防止其高糖基化和降解。该途径的破坏会损害 WNT 和 IGF1R 信号,并导致骨骼发育障碍成骨不全症。因此,N-糖基化可以通过 ER 中的特异性因子来调节,以控制细胞表面受体信号和组织发育。